# Title
Gemfibrozil B-Chemical
inhibits O
CYP2C8-mediated O
cerivastatin B-Chemical
metabolism O
in O
human B-Species
liver O
microsomes. O

# Abstract
To O
explore O
the O
mechanism O
of O
the O
interaction O
between O
gemfibrozil B-Chemical
and O
cerivastatin, B-Chemical
the O
enzyme O
mapping O
of O
the O
oxidative O
metabolism O
of O
cerivastatin B-Chemical
and O
the O
effect O
of O
gemfibrozil B-Chemical
on O
cerivastatin B-Chemical
metabolism O
were O
studied O
using O
human B-Species
liver O
microsomes O
and O
expressed O
cytochrome B-Gene
p450 B-Gene
(p450) B-Gene
CYP2C8 B-Gene
and I-Gene
3A4 I-Gene
isoforms. O
Based O
on O
studies O
with O
isoform-selective O
chemical O
inhibitors O
and O
expressed O
enzymes, O
CYP2C8 B-Gene
and O
CYP3A4 B-Gene
were O
equally O
important O
in O
the O
formation O
of O
desmethylcerivastatin B-Chemical
(M-1), O
whereas O
the O
formation O
of O
the O
quantitatively O
most O
important O
hydroxy O
metabolite O
(M-23) B-Chemical
was O
predominantly O
mediated O
via O
CYP2C8; B-Gene
other O
p450 B-Gene
isoforms O
played O
a O
negligible O
role. O
In O
human B-Species
liver O
microsomes, O
gemfibrozil B-Chemical
markedly O
inhibited O
M-23 B-Chemical
formation, O
with O
a O
K(i) O
(IC(50)) O
value O
of O
69 O
(95) O
micro O
M, O
whereas O
inhibition O
of O
M-1 O
formation O
was O
weaker O
with O
a O
K(i) O
(IC(50)) O
value O
of O
273 O
(>250) O
micro O
M. O
The O
inhibitory O
effect O
of O
gemfibrozil B-Chemical
was O
attributable O
to O
inhibition O
of O
CYP2C8 B-Gene
rather O
than O
CYP3A4, B-Gene
as O
evidenced O
by O
potent O
inhibition O
of O
the O
formation O
of O
M-23 B-Chemical
(IC(50) O
= O
68 O
micro O
M) O
and O
M-1 O
(IC(50) O
= O
78 O
micro O
M) O
in O
recombinant O
CYP2C8 B-Gene
but O
not O
in O
recombinant O
CYP3A4. B-Gene
Additionally, O
gemfibrozil B-Chemical
inhibited O
paclitaxel B-Chemical
6 O
alpha-hydroxylation O
[K(i) O
(IC(50)) O
= O
75 O
micro O
M O
(91 O
micro O
M)], O
a O
CYP2C8 B-Gene
marker O
reaction, O
but O
did O
not O
inhibit O
testosterone B-Chemical
6 O
beta-hydroxylation O
(CYP3A4). B-Gene
The O
present O
in O
vitro O
findings O
suggest O
that O
inhibition O
of O
CYP2C8 B-Gene
activity O
by O
gemfibrozil B-Chemical
at O
least O
partially O
explains O
the O
interaction O
between O
gemfibrozil B-Chemical
and O
cerivastatin. B-Chemical
The O
formation O
of O
M-23 B-Chemical
acid I-Chemical
from O
cerivastatin B-Chemical
is O
mediated O
mainly O
by O
CYP2C8 B-Gene
and O
thus O
may O
be O
a O
suitable O
CYP2C8 B-Gene
probe O
reaction. O
Inhibition O
of O
CYP2C8-mediated O
metabolism O
by O
gemfibrozil B-Chemical
warrants O
further O
in O
vivo O
exploration. O